The association of a tobacco-specific biomarker and cigarette consumption and its dependence on host characteristics

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 9, 2007, Pages 1852-1857

  Lubin, Jay H ^a   Caporaso, Neil ^a   Hatsukami, Dorothy K ^b   Joseph, Anne M ^b   Hecht, Stephen S ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; COTININE; NICOTINE; NITROSAMINE 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RESEARCH; CIGARETTE SMOKING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GROUPS BY AGE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CARCINOGENS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NITROSAMINES; SEX FACTORS; SMOKING;

EID: 34548849109     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0018     Document Type: Article

References (31)

1. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinog 2002;23:907-22.
2. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998;11:559-603.
3. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon (France): IARC; 2006.
4. Joseph AM, Hecht SS, Murphy SE, et al. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev 2005;14:2963-8.
5. Vineis P, Alavanja M, Garte S. Dose-response relationship in tobacco-related cancers of bladder and lung: a biochemical interpretation. Int J Cancer 2004;108:2-7.
6. Vineis P, Kogevinas M, Simonato L, Brennan P, Boffetta P. Levellingoff of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res Rev in Mutat Res 2000;463:103-10.
7. Lubin JH, Caporaso N. Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev 2006;15:517-23.
8. Lubin JH, Alavanja MCR, Caporaso N, et al. Cigarette smoking and cancer: modeling total exposure and intensity. Am J Epidemiol 2007;166:479-89.
9. Lubin JH, Kogevinas M, Silverman DT, et al. Evidence for an intensity dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study. Int J Epidemiol 2007;36:236-41.
10. U.S. Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Washington (DC): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Superintendent of Documents, U.S. Government Printing Office; 2004.
11. Fagerstrom KO, Schneider NG. Measuring nicotine dependence - a review of the Fagerstrom tolerance questionnaire. J Behav Med 1989;12:159-82.
12. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence - a revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991;86:1119-27.
13. Hecht SS, Carmella SG, Chen ML, et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res 1999;59:590-6.
14. Benowitz NL, Perez-Stable EJ, Fong I, Modin G, Herrera B, Jacob P. Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther 1999;291:1196-203.
15. Perez-Stable EJ, Herrera B, Jacob P, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA 1998;280:152-6.
16. Etter JF, Perneger TV. Measurement of self reported active exposure to cigarette smoke. J Epidemiol Community Health 2001;55:674-80.
17. Law MR, Morris JK, Watt HC, Wald NJ. The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. Br J Cancer 1997;75:1690-3.
18. Abrams DB, Follick MJ, Biener L, Carey KB, Hitti J. Saliva cotinine as a measure of smoking status in field settings. Am J Public Health 1987;77:846-8.
19. Blackford AL, Yang G, Hernandez-Avila M, et al. Cotinine concentration in smokers from different countries: relationship with amount smoked and cigarette type. Cancer Epidemiol Biomarkers Prev 2006;15:1799-804.
20. Campuzano JC, Hernandez-Avila M, Jaakkola MS, et al. Determinants of salivary cotinine levels among current smokers in Mexico. Nicotine Tob Res 2004;6:997-1008.
21. Jaakkola MS, Ma JM, Yang GH, et al. Determinants of salivary cotinine concentrations in Chinese male smokers. Prev Med 2003;36:282-90.
22. Heinrich J, Holscher B, Seiwert M, Carty CL, Merkel G, Schulz C. Nicotine and cotinine in adults' urine: The German Environmental Survey 1998. Expo Anal Environ Epidemiol 2005;15:74-80.
23. Lewis SJ, Cherry NM, Niven RM, Barber PV, Wilde K, Povey AC. Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinic. Biomarkers 2003;8:218-28.
24. O'Connor RJ, Giovino GA, Kozlowski LT, et al. Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers. Am J Epidemiol 2006;164:750-9.
25. Olivieri M, Poli A, Zuccaro P, Ferrari M, et al. Tobacco smoke exposure and serum cotinine in a random sample of adults living in Verona, Italy. Arch Environ Health 2002;57:355-9.
26. Richie JP, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev 1997;6:783-90.
27. Hill P, Haley NJ, Wynder EL. Cigarette-smoking: carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease. J Chronic Dis 1983;36:439-49.
28. Hecht SS, Carmella SG, Kenney PMJ, Low SH, Arakawa K, Yu MC. Effects of cruciferous vegetable consumption on urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in Singapore Chinese. Cancer Epidemiol Biomarkers Prev 2004;13:997-1004.
29. Taioli E, Garbers S, Bradlow HL, Carmella SG, Akerkar S, Hecht SS. Effects of indole-3-carbinol on the metabolism of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone in smokers. Cancer Epidemiol Biomarkers Prev 1997;6:517-22.
30. Patterson F, Benowitz N, Shields P, et al. Individual differences in nicotine intake per cigarette. Cancer Epidemiol Biomarkers Prev 2003;12:468-71.
31. Lubin JH, Caporaso N, Wichmann HE, Schaffrath-Rosario A, Alavanja MCR. Cigarette smoking and lung cancer: modeling effect modification of total exposure and intensity. Epidemiol 2007;18:639-48.